Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03177655 · ClinicalTrials.gov registry record · NA
Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis
A NA study of Multiple Sclerosis, MS, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03177655: Completed NA study of Multiple Sclerosis, MS, sponsored by University of California, San Diego.
NCT03177655 is a NA study of Multiple Sclerosis, MS that has completed, run by University of California, San Diego. The registered enrollment target is 20 participants, below the 64-participant average among 7 other Multiple Sclerosis, MS trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03177655, a NA study of Multiple Sclerosis, MS, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-center interventional study quasi-randomly allocated patients to a guided imagery or control intervention (positive journaling). Data were analyzed with treatment allocation masked.
Primary Outcome
Quality of Life based on Multiple Sclerosis Quality of Life Instrument (MS-QOL-54)
Conditions Studied
Interventions
- OTHER Guided Imagery
- OTHER Journaling
Study Locations (1)
California
- University of California, San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-03-01 |
| Est. Completion | 2017-03-01 |
| Phase | NA |
What the finished NCT03177655 record still lists
NCT03177655 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 64-participant average among 7 other Multiple Sclerosis, MS trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Multiple Sclerosis, MS appearing as the primary indexed condition, and to 2 interventions - of which Guided Imagery is the first listed.
NCT03177655 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03177655 about?
NCT03177655 is a clinical study titled "Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis". This single-center interventional study quasi-randomly allocated patients to a guided imagery or control intervention (positive journaling). Data were analyzed with treatment allocation masked.
What is the current status of trial NCT03177655?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2012-03-01. Estimated completion is 2017-03-01.
What conditions does trial NCT03177655 study?
This clinical trial studies the following conditions: Multiple Sclerosis, MS.
What interventions are being tested in trial NCT03177655?
The interventions under investigation include: Guided Imagery (OTHER), Journaling (OTHER).
Who is sponsoring clinical trial NCT03177655?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03177655 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis, MS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Palliative Care Model Impact on Knowledge and Attitudes
RECRUITING · NA
-
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
RECRUITING · NA
-
Physical Activity in Persons Newly Diagnosed With Multiple Sclerosis
COMPLETED · NA
-
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
RECRUITING · Phase 1
-
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
RECRUITING · Phase 1
-
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI